COVID-19 Pandemic and Angina Pectoris: What If the Pain Pathway Is Pharmaceutically Modulated?

Pain Med. 2020 Nov 1;21(11):3246-3247. doi: 10.1093/pm/pnaa300.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Angina Pectoris / epidemiology
  • COVID-19*
  • China
  • Humans
  • Pain
  • Pain Management
  • Pandemics*
  • SARS-CoV-2